Ms Fiona Pak-Poy
Ms. Fiona Pak-Poy has worked in a variety of industries for companies ranging from start-ups to large public companies and not-for-profits. She currently serves as an independent non-executive director for MYOB (ASX:MYO); iSentia (ASX:ISD); and Novotech, a leading Asia-Pacific clinical research organisation. She is a member of the Federal Government’s Innovation and Science Biomedical Translation Fund (BTF) committee; a member of the Targeted Translation Research Accelerator (TTRA) Working Group tasked with assisting with the design of the TTRA initiative committed under the Medical Research Future Fund (MRFF); and a former member of the Federal Government’s Innovation Australia board.
Previously she has served on the boards of many entities including the commercialisation office of the University of Adelaide, Adelaide Research and Innovation. She was a partner in an Australian venture capital fund that invested in technology start-ups. Ms. Pak-Poy holds an Honours degree in Engineering from the University of Adelaide and an MBA from Harvard Business School.